All News

Researchers explore OTC naloxone sales sold independently at pharmacies and programmatically from 2023 to 2024.

Conversations about contraceptive options have grown more frequent—and often more polarized—on social media platforms.

Lisa Schwartz, PharmD, discusses community pharmacies’ displeasure with provisions backing the Medicare Drug Price Negotiation Program.

The FDA releases its updated recommendations and scientific considerations for the demonstration of safety and efficacy among biosimilars and their reference products.

A recent study reveals COVID-19 vaccine safety and varying disease activity impacts for systemic lupus erythematosus patients, highlighting important insights for immunization.

The regimen did not show signs of significant hypoglycemia and had a low prevalence of edema despite modest weight gain.

Leaders of the FDA, the US Department of Health and Human Services, and the Centers for Medicare & Medicaid Services announce new guidelines and a framework for less expensive biosimilar development.

Eli Lilly and Walmart collaborate to enhance access to Zepbound for obesity management, offering direct-to-consumer pricing and nationwide pharmacy pickup.

Alyssa Mack, PharmD, discusses events like the pandemic and new pharmacy laws that have allowed for an expansion of pharmacists’ scope of practice.

Pneumococcal conjugate vaccines significantly reduce pneumonia incidence in children, but safety concerns warrant further investigation in future studies.

Georgia Travlos, PharmD, discusses changes in influenza and respiratory syncytial virus immunizations and coadministration best practices.

A study reveals that lower baseline BMI and early weight loss with liraglutide enhance significant weight loss outcomes in patients with type 2 diabetes.

Patients and physicians favor at-home remdesivir treatment for COVID-19, highlighting satisfaction and confidence in telehealth and nursing support.

PCV21 improved all outcomes for individuals aged 19 to 64 years, including invasive pneumococcal disease, postmeningitis sequelae, and nonbacteremic pneumococcal pneumonia.

Research reveals no significant disparities in cardiovascular disease incidence linked to mental disorders after the COVID-19 pandemic.

Investigators explore how long COVID impacts trust in vaccines, revealing diverse patient experiences and the need for better communication in public health.

Pharmacists can help patients navigate the vast array of OTC options for effective pain relief, fever reduction, and targeted symptom management.

Steve Moore, PharmD, owner of Condo Pharmacy in Plattsburgh, New York, discusses his pharmacy’s ability to provide clinical services and the common roadblocks his team encounters.

Tezspire gains FDA approval as the first biologic for chronic rhinosinusitis with nasal polyps, offering improved patient outcomes.

The approval expands options for protecting infants from respiratory syncytial virus, which remains a leading cause of pediatric hospitalization.

National Check Your Meds Day, observed on October 21, is an important annual reminder of the value of these pharmacist-led interventions.

Pharmacy technicians seek recognition that values their contributions, emphasizing personal, professional, and practical appreciation to enhance morale and engagement.

FDA approves oral semaglutide for reducing cardiovascular risks in high-risk type 2 diabetes patients, enhancing treatment options and outcomes.

At the NCPA 2025 Annual Convention & Expo, Jeannie Grubbs, PharmD, manager at Publix Pharmacy, presented on the reasons why pneumococcal vaccine development is an ongoing process.

A recent study reveals a heightened stroke risk in asthma patients recovering from severe COVID-19, emphasizing the need for proactive monitoring and management.

Pennsylvania’s departments of health and human services provided written guidelines to support community pharmacists in delivering care for patients with opioid use disorder.

The FDA expands Yuflyma's approval to treat hidradenitis suppurativa and uveitis in pediatric patients, enhancing treatment options for chronic conditions.